Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0002043317-26-000006

Chief Commercial Officer acquired 168 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Evans Terry L Chief Commercial Officer 2026-05-31 Grant or award +168 21,015 D: show line 1 in the form
Loading xslF345X06/form4-06012026_040607.xml…